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Sinary Over the past 10 years, the orginal rtnership of clnician and statstcian for the running of
chnical rarch projects, especially cinical trials, has come to be supplemented by the data manager and trial
coordinator. Increasing numbers of such personnel are now being employed, covering a wide diversity of work
areas, iling cinical researh, nedical audit and the cancer registr. The Bntish Oncology Data Manages
Association (BODMA) was founded in 1987 and is now in a good position to review the current status ofdata
management in the UK. It is proposed that a national network ofdata manages and trial coordinators within
specialist trials centres, oncoy departments and distit general hospitals, with a good taining progamme,
phls a recognsed carer stucture, is the way to make the best use of this key resource. BODMA is addressig
many of these issues and aims to improve and maintain the quality of data management.
The gold standard of clinical research, the controlled, pro-
spective trial (Gelber & Goldhirsch, 1988) from phase I to
phase III, is invariably a collaborative, multidisciplinary pro-
ject. Any trial is a major and costly enterprise, frequently
taking many years to complete. Success depends upon correct
design, careful planning, meticulous execution and provision
of adequate resources. Once the basic protocol has been
agreed, the actual execution becomes largely a matter of
teamwork and good administration. To detect small but
beneficial improvements in treatment outcome, large numbers
of patients are required, and hence trials, especally of
adjuvant therapy, are becoming larger and almost universally
multicentre. Over the past 10 years, the original parnership
of clinkian and statistician has come to be supplemented by
a new professional - the trial coordinator or data manager -
who is responsible for running the study. As Warlow (1990)
has written, these generalists who specialise in 'maing it
work' are key personnel with a wide range ofdisparate sklills.
Increasing numbers are employed with a range of experience,
expertise and responsibilities, from the speciast clerk (data
manager) through to the fully fledged project scientist/
manager (trial coordinator), and are to be found within
many different environments: dedicated clinical trials centres,
specialist oncology departments and district geneal hospitals.
Tbeir involvement in clinical research and trials in parbcular
can range from the tightly controlled phase I/IH drug
development trials to the large, more pragmatic, phase Ill
treatment evaluation trials.
This is a new and still developing profession that is coming
of age in a time ofchange and uncertainty over the future of
medical research (Ward, 1992; Sonhami, 1993). Data man-
agement issues will play a key role in determining the
feasibility and organisation of future, large-scale phase mI
studies and in meeting the (higher) standards now being
issued for the running of trials, including phase I and II
studies, to good clinical practice (GCP).
The British Oncology Data Manars Association (BODMA)
was formed in 1987 and is the first data mnagement group
in the UK. This group is comnitted to creating training
programmes, raising standards of data management and
developing proper career paths. It is widely accepted that
these aspects are necessary, and BODMA in collaboration
with the EORTC Study Group in Data Management
(EORTC-SGDM) is now beginning to move actively towards
achieving these goals. Groups such as BODMA are also
being formed throughout other parts of the world, and they
regularly share their experiences via meetings and newsletters.
However, it must be Lemembered that all aspects of data
management relate to many other areas in addition to clinical
trials such as medical audit, screeing programmes and the
cancer registries. Data managers and trial coordinators in the
UK are responding to the demands and chalenges before
them by demonstrating an incased professionalism and
addressing these issues seriously.
Tle Bfti Owoky Data M Asoatoi
The British Oncology Data Managers Association (BODMA)
was formed by a group of like-minded data manages and
trial coordinators in December 1987 (Riley & Lennon, 1990).
Our aim, as already mentioned, is to improve the quality of
trial managment in the UK by ending the isolation still
experienced by many workers outside the largr trial centres,
and to address the training needs and professional develop-
ment of data managers. Six years on it is time to report on
our progress and to evaluate the options for future develop-
ment of oncology data m a t in the UK.
Membership
We first identified data manager and trial coordinators as a
specific group within research bodie and the NHS, and
ascertained their interests and problems. While membership
is open to non-oncology data manags and interested
workers from other related fiekls, e.g. the cancer registrs,
the majority of our members are employed within oncology
clinical trials. This article is about them.
Membership currently stands at 170. However, some
potential members workling in hospitals or dedicated clinical
trials centres and oncology centres are still not represented
despite our efforts. Our recruitment campaign continues.
Who is a data manager or trial coordinator?
The validity of any conclusions drawn from clinical research
depends crtically on good experimental design, proper execu-
tion and correct analysis (Pocock, 1983; Fowkes et al., 1991).
Performing good, controlled scientific studies in human sub-
jects is a very complex area. It is widely accepted that the
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design, coordination and analysis of modem trials requires a
multidisciplinary specialist approach. In the UK, there are a
number of specialist trials offices primarily funded by the
cancer charities (CRC and ICRF) and the Medical Research
Council (MRC), each with specific remits.
The editorial policy of many scientific journals now
emphasises the importance of statistical input and correct
analyses. Since good results can never be extracted from poor
data, it is perhaps surprising that the acceptance of the need
for professional data managers and trial coordinators has
lagged behind that of defined statistical methods (Neaton et
al., 1990). Historically, data management staff were co-opted
from other fields with a variety of backgrounds - nursing,
secretarial, computing and basic research to name but four.
Despite their varied roles in different centres, the success or
failure of a trial often falls largely within the domain of the
data management and trial coordination team, whose main
responsibilities include ensuring strict adherence to the pro-
tocol, obsessively accurate data collection and continuous
enthusiasm throughout the period of recruitment and follow-
up. In consequence, trials, especially large multicentre ones,
have become increasingly dependent upon the services of the
trial coordinator or data manager. Their need for access to
formal training and a proper career structure is increasingly
recognised (Haybittle, 1988) by all involved in clinical trials.
In a recent survey of our members conducted in 1992 93
respondents (out of 153 questionnaires sent) (79%) thought
that a national career structure should now be established.
Ninety per cent were in favour of BODMA being instrument-
al in organising relevant training courses, with 79% of
members wishing for courses to be targeted at different levels
of membership. Most members (75%) thought their em-
ployers would encourage them to attend such courses if they
were available.
Much of the routine data management work, e.g. patient
registration, data extraction, data input and trial secretariat
work, is largely clerical in nature and can be delegated to
junior data managers or research secretaries. Since good data
management (at any level) will always require a basic under-
standing of the diseases being studied, a clear view of the
requirements of the 'experiment' is needed, particularly in
complex phase I and phase II trials of new drugs. Therefore
the junior data manager may best be equated with laboratory
technical staff, or as being in an entry level training position
prior to taking further responsibility. These personnel are
required to be meticulous about data collection and their
responsibility for generating important, valuable data ofhigh
quality is generally overlooked (Vantongelen et al., 1989,
1991; Meharchand & Tannock, 1991).
As in all professions there are a small proportion of data
managers and trial coordinators who are extremely well
qualified, from both the academic and experience viewpoint.
This is reflected by the fact that over 40% of BODMA
members are graduates and 17 (19%) hold higher degrees.
The training of a trial coordinator must aim to eventually
produce a research scientist capable of guiding a study from
design to analysis. 'Senior data managers' or Trials coor-
dinators', whatever their title, will often act as the main link
between collaborative groups and participating clinicians in
the larger multicentre studies. It is in everyone's interest that
they are capable of fulfilling such a demanding role and will
remain in-post for a reasonable period of time.
The above two examples represent the extreme. Between
them there exists an intermediate level (e.g. the new graduate
in training). Irrespective of the type of position held, the role
of the data manager and trial coordinator is a varied and
multifaceted one.
Throughout the UK, as elsewhere, the pattern of develop-
ment is one of gradual centralisation of key resources and
skills through the creation of specialist centres for data man-
agement and statistics. However, the current position is that
many data managers are employed independently within hos-
pital departments, rather than having links with specialist
centres. Under the new purchaser/provider arrangements
within the NHS, demand for data management support for
the additional work involved in participating in trials can be
expected to increase. Since it is this group who are poten-
tially most isolated, they have the greatest need for training
and thus the most to gain from BODMA. The success of
future trials will depend critically on our ability to meet this
need.
Curret s
A national network oftrial coordinators and data managers?
Trials depend upon the efforts of many clinicians based in
both specialist and general hospitals who are prepared to
enter patients into collaborative protocols. Many clinicians
a're interested in addressing good scientific questions but feel
they have too little time, inadequate resources to complete
the necessary paperwork or no access to any data manage-
ment support. Some recent trials have tried to resolve this
problem by requesting only the minimum of information.
This tactic is feasible only in a few situations, and peripheral
topics of great interest may have to be abandoned in order to
answer the main question.
Patients can only be recruited from the setting within
which they initially present for management. It is vital to
have appropriate staff and procedures in place locally to
identify suitable subjects and ensure that they are offered an
opportunity to join the study. It would seem logical to
suggest that an attempt be made to coordinate the limited
resources available to provide the clinician with access to
improved local data management support. Such staff could
accept local responsibility for coordinating selected trials,
help identify potential patients and perform much of the
extra paperwork. They would act to promote, and more
importantly sustain, interest in trial participation, which
should enable increased participation byremoving the restric-
tions from other staff resources (Farrar, 1991).
In order to offer job satisfaction and provide the expected
quality of data management the 'on-site' data collectors
should have relevant experience and could be affiliated to an
appropriate trials centre for supervision and training. In the
USA, the NSABP and ECOG groups have achieved con-
siderable success in recruiting through the 'outreach model',
which places staff and resources within community centres.
Other groups too report the success of the multicentre col-
laborative team approach (Begg et al., 1982; Fleming, 1989;
Freedman, 1989; Friedman & Cain, 1990; Farrar, 1991;
Franklin et al., 1992). They have also seen improvement in
data quality and an increased acceptance of methodology as
results penetrate into practice. The data managers concerned
benefit from the training, newsletters, quality control and
supervision which the specialist centre provides.
The situation in the UK is moving towards a point where
such a model could begin to be implemented here, perhaps
funded through the auspices of the UKCCCR or new DOH
research initiatives and admin using the existing net-
work of trials centres which geographically cover the UK.
We could invest resources in establishing a national network
of 'on-site' local personnel within hospitals to enable them to
recruit reasonable numbers of patients into trials of major
national interest (Souhami, 1993). It would require extensive
collaboration and goodwill to set up the initial structure and
mechanisms, but the potential benefits should easily repay
the effort. Funding for such posts could be shared between a
number of different studies/funding bodies in order to create
more secure positions. Such a scheme could initially con-
solidate existing posts, especially those whose holders'
experience and expertise would be missed most from the
'pool' upon the curtailment of a short-term contract. Seventy
per cent of current BODMA members have no security of
tenure and are employed on short-term contracts.
Data managers such as these would be attached to the
nearest or most appropriate trials centre for purposes of
training, personal development, etc. They might be expected
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mote several protocols, even for different trials groups. The
sharing of resources and experience between trials and the
possible projected increase to recruitment into trials should
make it cost-effective in the long term.
Career development and training
BODMA produces a biannual newsletter, and since 1987
BODMA has organised sLx national annual meetings.
Regional meetings and workshops have also been held. The
overriding aim in all of these is to improve the 'quality of
clinical trials and raise standards for data managers and trial
coordinators alike. Most members have now had the oppor-
tunity to visit the larger clinical trials centres in their area,
and informal links are being formed between the peripatetic
data manager and the specialist trials centres.
A centrally coordinated network of data managers and
trial coordinators would have advantages for training pro-
grammes and establishing a career sructure. Currently very
few relevant courses are available, which results in virtually
all new team members at whatever level receiving no appro-
priate training. BODMA members have a wide variety of
backgrounds, interests, abilities and aspirations. Sadly
though, many experienced trial coordinators and data
managers are leaving the 'profession' because of lack of
direction, a shortage of senior positions and uncertainty over
funding. Only 34% (32) of members have been employed
within this field for more than 4 years, and 31% (29) for less
than 2. The latter figure of 31% does not reflect an increase
of new posts as our total membership has remained relatively
static at 170 for the last few years. A career structure,
however, relies upon a good training programme, universally
recognised levels of knowledge and expertise and the desire
to stay within the established framework.
BODMA has identified the training/learning requirements
of data managers and trial coordinators as falling into five
categories:
1. Induction courses for new trial coordinators and data
managers, covering areas related to the rationale of
clinical trials and practical aspects for data management.
2. Specialised in-depth workshops for more experienced trial
coordinators and data managers in key areas such as trial
methodology, database management, presentation skills,
statistics and site-specific aspects (e.g. breast, gyn-
aecological), such as risk/prognostic factors, natural his-
tory, current treatment regimens plus quality of life issues.
3. General meetings, at which members can discuss and pre-
sent wider issues affecting oncology data managet.
4. Collaborative meetings with related data management and
medically orientated associations about topics of mutual
interest in oncology.
5. Encouraging original research into aspects of trial
methodology, especially with regard to the 'mechanics' of
coordinating trials and maintaining patient recruitment.
With the relatively high personnel turnover seen in the
early years of employment, there will always be new data
managers requirng training. The first BODMA clinical trials
induction course is scheduled for the summer of 1994 and
will hopefully set the standard for future UK courses.
Previously the EORTC-SGDM organised a successful 1 week
induction course for the 'new' data manager in 1991. An
integral part of this course was a second week spent in a
trials centre to gain alternative 'work experience'. Although
not yet incorporated into the BODMA course a national
network of data managers would malke such placeents
easier and offer a choice of being involved at the clinical end
as an 'on-site' data collector or being involved in the coor-
dination role.
In 1993 the first joint venture occurred between the
European School of Oncology (ESO), BODMA and the
EORTC-SGDM group, an intensive advanced-level course in
cancer clinical trials. Courses such as these are relatively
expensive, but funding to attend them could be incorporated
into the budget for establishing any new trial. These are
exciting first steps on the way to providing our members with
what they want and our employers with access to trained,
competent staff.
Liaison with other groups
BODMA not only provides a forum for data managers
within the UK, but has formed close workcing links with the
EORTC-SGDM. Similar contacts with groups in the USA,
Canada, Australia and New Zealand have been made. How-
ever, it is not only other data management groups with which
BODMA has liaised, several joint ventures have been under-
taken in collaboration with groups such as the Oncology
Section of the RSM and the British Psychosocial Oncology
Group. BODMA enjoys the support of many individual
clinicians and heads of department, along with the major
trials centres and medical associations.
Comcaiom
In many areas, this association has achieved considerable
sucss, especially with regard to training and raising the
profile of data management. The sustained level of member-
ship demonstrates the continued need of many data
managers and trial coordinators for contact with their peers
and exposure to the wider possibilities of their work. The six
annual national meetings regularly attract 70% attendance,
and the several joint ventures with other medical associations
have been deemed mutually beneficial and successful.
Several observations can now be made:
1. Data managers and trial coordinators want a professional
forum such as BODMA, through which to express their
views, exchange ideas and report their research findings.
2. There is a place for the experienced, professional,
scientifically trained trial coordinator able to work along-
side clinicians and statisticians, in addition to the commit-
ted data manager, responsible for trial administration
based within the local hospital or trials centre.
3. National training courses are needed to provide basic and
advanced training in data mnagenment. This might help to
reduce the high staffturnover currently seen and retain the
base of knowledge currently available within the field of
oncology clinical trials.
4. The development of a defined career structure and
enhanced job security should be a priority.
5. The time is now right to address the feasibility of setting
up a more formal network of trial coordinators and data
managers in the UK.
If these issues can be satisfactorily addressed, the quality of
data mangement in the UK will improve. This can only be to
the advantage of clinical trials activity in this country.
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